Paul T Finger1, Kimberly J Chin. Show Affiliations » 1. Department of Ophthalmology, New York Eye and Ear Infirmary, New York, NY 10065, USA. pfinger@eyecancer.com
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAgedAged, 80 and overAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal, HumanizedBrachytherapy/adverse effectsChoroid Neoplasms/radiotherapyFemaleFluorescein AngiographyHumansInjectionsMacula Lutea/radiation effectsMacular Edema/drug therapyMacular Edema/etiologyMaleMelanoma/radiotherapyMiddle AgedPalladium/adverse effectsRadiation Injuries/drug therapyRadiation Injuries/etiologyRadioisotopes/adverse effectsRanibizumabRetinal Diseases/drug therapyRetinal Diseases/etiologyRetinal Hemorrhage/drug therapyRetinal Hemorrhage/etiologyRetinal Neovascularization/drug therapyRetinal Neovascularization/etiologyTomography, Optical CoherenceVisual AcuityVitreous Body
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedRadioisotopesPalladiumRanibizumab
Year: 2010 PMID: 20142553 DOI: 10.1001/archophthalmol.2009.376
Source DB: PubMed Journal: Arch Ophthalmol ISSN: 0003-9950